TABLE 1.
Treatment (trial) | Fractiona | Amt of Stx (ng/ml) | Stx binding (ng of Stx/cell)
|
|
---|---|---|---|---|
Before washb | After washc | |||
Stx2 (1) | Plasma | 523 | ||
PBMC | 317 | 1.0 × 10−4 | 2.5 × 10−6 | |
Neutrophil | 39 | 1.8 × 10−5 | BDLd | |
RBC | 13 | Not determined | Not determined | |
Stx2 (2) | Plasma | 643 | ||
PBMC | 310 | 1.2 × 10−4 | 9.8 × 10−7 | |
Neutrophil | 127 | 4.7 × 10−5 | BDL | |
RBC | 7 | Not determined | Not determined | |
Stx1 (1) | Plasma | 1,022 | ||
PBMC | 589 | 4.0 × 10−4 | BDL | |
Neutrophil | 168 | 5.3 × 10−5 | BDL | |
RBC | 51 | Not determined | Not determined |
Approximately 5 μg of Stx1 or Stx2 was added to 3.5 ml of blood, incubated at 37°C for 1 h, and fractionated over Mono-Poly resolving medium.
The numbers of cells in PBMC and neutrophil fractions were determined by flow cytometry and used to calculate the ng of Stx per cell.
Cells were washed once in PBS prior to ELISA.
BDL, below the detection limit.